Efficacy of eplerenone versus enalapril as monotherapy in systemic hypertension
- 15 April 2004
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Cardiology
- Vol. 93 (8) , 990-996
- https://doi.org/10.1016/j.amjcard.2004.01.007
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Long-term safety and efficacy of the selective aldosterone blocker eplerenone in patients with essential hypertensionClinical Therapeutics, 2003
- Symptoms and the Distress They CauseArchives of internal medicine (1960), 2003
- Efficacy and tolerability of eplerenone and losartan in hypertensive black and white patientsJournal of the American College of Cardiology, 2003
- Eplerenone, a selective aldosterone blocker, in mild-to-moderate hypertensionAmerican Journal of Hypertension, 2002
- Essential Hypertension of Caribbean Hispanics: Sodium, Renin, and Response to TherapyThe Journal of Clinical Hypertension, 2002
- A multicenter, randomized, double-blind comparison of the efficacy and safety of irbesartan and enalapril in adults with mild to moderate essential hypertension, as assessed by ambulatory blood pressure monitoring: The MAPAVEL studyPublished by Elsevier ,2002
- A multicenter, randomized, double-blind study of the antihypertensive efficacy and tolerability of irbesartan in patients aged ≥65 years with mild to moderate hypertensionClinical Therapeutics, 2000
- Aldosterone: A Mediator of Myocardial Necrosis and Renal Arteriopathy*Endocrinology, 2000
- Putative mechanisms of cough after treatment with angiotensin converting enzyme inhibitorsJournal Of Hypertension, 1995
- Differing Mechanisms of Action of Angiotensin-Converting Enzyme Inhibition in Black and White Hypertensive PatientsHypertension, 1995